MATUCCI, Andrea
 Distribuzione geografica
Continente #
EU - Europa 2.656
NA - Nord America 2.450
AS - Asia 1.829
SA - Sud America 234
AF - Africa 19
OC - Oceania 5
Continente sconosciuto - Info sul continente non disponibili 1
Totale 7.194
Nazione #
US - Stati Uniti d'America 2.383
RU - Federazione Russa 1.032
SG - Singapore 800
GB - Regno Unito 697
CN - Cina 610
BR - Brasile 195
IT - Italia 160
HK - Hong Kong 156
SE - Svezia 156
DE - Germania 137
FR - Francia 124
FI - Finlandia 116
IE - Irlanda 109
VN - Vietnam 91
KR - Corea 69
CA - Canada 47
UA - Ucraina 42
PL - Polonia 21
BE - Belgio 19
IN - India 17
TR - Turchia 17
JP - Giappone 15
MX - Messico 15
ES - Italia 14
ID - Indonesia 12
AR - Argentina 11
ZA - Sudafrica 11
EC - Ecuador 10
AT - Austria 7
IQ - Iraq 7
BD - Bangladesh 6
AE - Emirati Arabi Uniti 5
IL - Israele 5
VE - Venezuela 5
AU - Australia 4
CL - Cile 4
CO - Colombia 4
NL - Olanda 4
UZ - Uzbekistan 4
JO - Giordania 3
KE - Kenya 3
LT - Lituania 3
PK - Pakistan 3
AZ - Azerbaigian 2
BO - Bolivia 2
CH - Svizzera 2
CZ - Repubblica Ceca 2
EG - Egitto 2
HU - Ungheria 2
KZ - Kazakistan 2
LV - Lettonia 2
PH - Filippine 2
PY - Paraguay 2
BG - Bulgaria 1
CR - Costa Rica 1
CV - Capo Verde 1
DO - Repubblica Dominicana 1
EU - Europa 1
GA - Gabon 1
GR - Grecia 1
GY - Guiana 1
JM - Giamaica 1
LU - Lussemburgo 1
MA - Marocco 1
MY - Malesia 1
NI - Nicaragua 1
NO - Norvegia 1
NZ - Nuova Zelanda 1
PA - Panama 1
RO - Romania 1
RS - Serbia 1
SA - Arabia Saudita 1
SI - Slovenia 1
TL - Timor Orientale 1
Totale 7.194
Città #
Southend 636
Singapore 391
Jacksonville 357
Moscow 338
Chandler 293
Ashburn 191
Dallas 185
Woodbridge 161
Hong Kong 156
Ann Arbor 145
Dublin 108
Houston 107
Beijing 102
Los Angeles 60
Nanjing 55
New York 54
The Dalles 52
Lawrence 42
Princeton 42
Wilmington 40
Munich 39
Jinan 35
Verona 34
Ho Chi Minh City 33
Boardman 31
Seattle 29
Tianjin 27
Buffalo 25
Sindelfingen 25
Hebei 24
Seoul 23
Shenyang 23
Hanoi 22
Helsinki 22
Milan 22
Changsha 21
Nanchang 21
Warsaw 19
Brussels 18
Hangzhou 18
São Paulo 18
Zhengzhou 18
Taizhou 17
Haikou 16
Montreal 16
Chicago 15
Ningbo 15
Redondo Beach 15
Cambridge 14
Elora 14
Tokyo 14
Turku 14
Denver 13
Jiaxing 13
Santa Clara 13
Columbus 12
Council Bluffs 12
Taiyuan 11
San Francisco 10
Chennai 9
Toronto 9
Cagliari 8
Johannesburg 8
Poplar 8
Brooklyn 7
Clearwater 7
Guangzhou 7
Mexico City 7
Atlanta 6
Bologna 6
Frankfurt am Main 6
Fuzhou 6
Lanzhou 6
London 6
Norwalk 6
Redmond 6
Ankara 5
Da Nang 5
Phoenix 5
Querétaro 5
Quito 5
Arco 4
Belo Horizonte 4
Curitiba 4
Dongguan 4
Falkenstein 4
Jakarta 4
Lancaster 4
Nanyang 4
Orem 4
Rome 4
Roubaix 4
San Jose 4
Stockholm 4
Tashkent 4
Vienna 4
Amman 3
Amsterdam 3
Bexley 3
Brasília 3
Totale 4.511
Nome #
New immunogens for the induction of broad spectrum neutralizing antibodies against human immunodeficiency virus type 1 (HIV-1) 237
Autologous cellular vaccine overcomes cancer immunoediting in a mouse model of myeloma 227
Broad spectrum neutralizing monoclonal antibodies against HIV-1 elicited by immunizing with fusion complexes 205
Broad spectrum neutralizing antibodies against HIV-1 elicited by immunizing with fusion complexes and CD4-independent gp120/41s. 205
HLA-C is necessary for optimal HIV-1 infection of human peripheral blood CD4 lymphocytes 204
Expression of HIV-1 NDK m9 env gene in eukaryotic cells for the induction of HIV-1 neutralizing antibodies 199
Fusion complexes and CD4-independent Env for the induction of broad spectrum neutralizing antibodies against HIV-1 199
Induction of human immunodeficiency virus neutralizing antibodies using fusion complexes 196
Fusion complexes and CD4-independent gp120s for the induction of HIV-1 neutralizing antibodies 195
Induction and expansion of an anti-tumor immune response by B7-1+ tumor cells in dependence on the anatomical site of delivery and the dose applied 193
Presence and role of HLA-C in HIV-1 infection 190
Fusion complexes and CD4-independene Env for the induction of broad spectrum neutralizing antibodies against HIV-1 189
Temperature-dependent decay of wheat germ agglutinin activity and its implications for food processing and analysis 183
Analysis of mammalian scrapie protein by novel monoclonal antibodies recognizing distinct prion protein glycoforms: an immunoblot and immunohistochemical study at the light and electron microscopic levels. 182
Studio di immunogeni per l'induzione di anticorpi neutralizzati ad ampio spettro contro il virus dell'immunodeficienza umana (HIV-1) 181
Expression of HIV-1 NDK m7 and m9 env genes in eukaryotic cells for the induction of HIV-1 neutralizing antibodies 179
Demonstration of the role of HLA-C in HIV-1 infection by siRNA silencing 170
Induction of an antitumour adaptive immune response elicited by tumour cells expressing de novo B7-1 mainly depends on the anatomical site of their delivery: the dose applied regulates the expansion of the response 168
Induction of HIV-1 neutralizing antibodies by fusion complexes 167
Broad spectrum neutralizing antibodies against HIV-1 elicited by immunizing with fusion complexes 161
Studies on the joint cytotoxicity of wheat germ agglutinin and monensin 158
Fusion complexes as immunogens for the induction of broad spectrum neutralizing antibodies against HIV-1 158
Expression and purification of recombinant HTLV-2 Tax protein in mammalian cells 154
Fusion efficiency between the HIV-1 envelope and the target cell membrane is enhanced by the presence of HLA-C molecules 153
Induction of human immunodeficiency virus (HIV) neutralizing antibodies with fusion complexes 152
HLA-C increases fusion efficiency between the HIV-1 envelope and the cell membrane and is part of the fusion complex 152
Broad spectrum neutralizing antibodies against HIV-1 elicited by immunizing with fusion complexes 149
Asthma in a large COVID-19 cohort: Prevalence, features, and determinants of COVID-19 disease severity 147
COVID-19 in severe asthmatic patients during ongoing treatment with biologicals targeting type 2 inflammation: Results from a multicenter Italian survey 135
Fusion complexes and CD4-independent gp120s for the induction of HIV-1 neutralizing antibodies 134
Asthma control in severe asthmatics under treatment with omalizumab: A cross-sectional observational study in Italy 130
Fusion complexes and CD4-independent gp120s for the induction of broad spectrum anti HIV-1 neutralizing antibodies 128
HLA-C increases HIV-1 infectivity and is associated with gp120 128
Induction of human immunodeficiency virus (HIV) broad spectrum neutralizing antibodies with fusion complexes. 120
Presence and Role of HLA-C in HIV-1 Infection 114
Fusion complexes as broad spectrum anti-HIV vaccine 106
Changes in the Adaptive Cellular Repertoire after Infection with Different SARS-CoV-2 VOCs in a Cohort of Vaccinated Healthcare Workers 104
Studio di nuovi immunogeni per l'induzione di anticorpi neutralizzanti ad ampio spettro contro il virus dell'immunodeficienza umana (HIV-1) 96
Choosing wisely: practical considerations on treatment efficacy and safety of asthma in the elderly 96
Use of gp120-CD4-coreceptor fusion complexes and CD4-independent gp120s for the induction of HIV-1 neutralizing antibodies 94
Induction of HIV neutralizing antibodies using fusion complexes and a CD4-independent env 91
HLA-C increase fusion efficiency between the HIV-1 envelope and the cell membrane and is part of the fusion complex 89
Study of the optimal conditions for obtaining fusion complexes to be used as broad spectrum anti HIV-1 vaccine 86
Higher blood eosinophil levels after omalizumab treatment may be associated with poorer asthma outcomes 84
Immune signature in vaccinated versus non-vaccinated aged people with COVID-19 pneumonia 76
Persistence of both reversible airway obstruction and higher blood eosinophils may predict lung function decline in severe asthma 75
HLA class I increases the efficiency of fusion between the HIV-1 envelope and the target cell membrane and is parte of the fusion complex between the gp120/gp41 and the cellular receptors. 69
Managing Patients with Hypereosinophilic Syndrome: A Statement from the Italian Society of Allergy, Asthma, and Clinical Immunology (SIAAIC) 56
HLA-C increases HIV-1 infectivity 33
null 33
Tezepelumab in patients with allergic and eosinophilic asthma 32
Multidisciplinary Decision-Making—ITAlian Consensus After Two Years of Real Practice on the Management of Severe Uncontrolled CRSwNP by Biologics (ITACA Study) 32
null 32
Totale 7.226
Categoria #
all - tutte 23.767
article - articoli 11.062
book - libri 0
conference - conferenze 11.916
curatela - curatele 0
other - altro 789
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 47.534


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021203 0 0 0 0 0 57 6 38 43 10 44 5
2021/2022361 42 107 4 30 5 6 3 22 12 9 32 89
2022/2023843 69 101 76 130 86 193 3 55 91 8 20 11
2023/2024376 13 37 24 47 46 56 11 25 3 30 44 40
2024/20251.135 39 71 18 133 44 37 83 46 209 107 90 258
2025/20262.421 255 127 230 581 951 277 0 0 0 0 0 0
Totale 7.226